# Senseonics, Inc.

Organization · id `cardio:org-senseonics-inc` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Senseonics%2C+Inc.>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 4 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Senseonics, Inc.
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: PROMISE Study: An Evaluation of an Implantable Continuous Glucose Sensor up to 180 Days (`cardio:ct-nct03808376`)
- Sponsors: Post Approval Study of the Eversense® Continuous Glucose Monitoring (`cardio:ct-nct03908125`)
- Sponsors: Eversense® Non-adjunctive Use Post Approval Study (`cardio:ct-nct04836546`)
- Sponsors: Enhance Study: Evaluation of Accuracy and Safety of the Eversense CGM System With Enhanced Features (`cardio:ct-nct05131139`)

## Provenance

Content hash: f2951f4b575920ceae44a1bf48ff831aeb2173e885594700ff71f664abd87672
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
